Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 624.75M | $ 192.07M | 30.74% |
3/31/2025 | $ 631.94M | $ 189.96M | 30.06% |
12/31/2024 | $ 656.2M | $ 187.46M | 28.57% |
9/30/2024 | $ 645.12M | $ 178.67M | 27.7% |
6/30/2024 | $ 651.37M | $ 169.33M | 26% |
3/31/2024 | $ 652.68M | $ 164.14M | 25.15% |
12/31/2023 | $ 648.44M | $ 177.84M | 27.43% |
9/30/2023 | $ 641.61M | $ 194.28M | 30.28% |
6/30/2023 | $ 641.68M | $ 217.52M | 33.9% |
3/31/2023 | $ 644.53M | $ 233.3M | 36.2% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for VANDA PHARMACEUTICALS INC is calculated as follows: GP [ $ 218.27M ] / Assets [ $ 515.9M ]
(=) GPA [ 42.31% ]
Minimum
Mar 31, 2024
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 4.14K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.15% |
median | 15.34% |
std | 19.95% |